Market Research Report

Global Regenerative Medicine Market Research Report: Forecast (2024-2030)

Regenerative Medicine Market - By Product (Cell Therapy, Gene Therapy, Tissue Engineering), By Application (Oncology, Musculoskeletal Disorders, Dermatology & Wound Care, Cardiovas...cular Diseases, Ophthalmology, Neurology, Others) and other Read more

  • Healthcare
  • May 2024
  • 245
  • PDF, Excel, PPT

Market Definition

Regenerative medicine is a multidisciplinary field that focuses on harnessing the body's natural healing processes to repair, replace, or regenerate damaged tissues & organs. It utilizes various approaches, including stem cell therapy, tissue engineering, and biomaterials to restore normal function in diseased or injured tissues.

Market Insights & Analysis: Global Regenerative Medicine Market (2024-30):

The Global Regenerative Medicine Market size is estimated to grow at a CAGR of around 22.3% during the forecast period, i.e., 2024-30. In recent years, the landscape of medicine has undergone a profound transformation, marked by a growing emphasis on personalized therapeutic approaches. This shift has been catalyzed by remarkable advancements in biological therapies, prompting a preference for tailored treatment strategies over conventional methods. Consequently, companies specializing in biological therapeutics have risen to prominence, capitalizing on the burgeoning demand for personalized medicine.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 22.3%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled Novartis AG, Biogen Inc., Amgen Inc., Sarepta Therapeutics Inc.,, Medipost Co. Ltd.,, Smith+Nephew, JCR Pharmaceuticals Co. Ltd, Takeda Pharmaceuticals, Corestem Inc., Vericell Corporation, Organogenesis Inc., Medtronic, MiMedx Group, Inc., Bristol Myers Squibb Company, Orthocell Ltd., Others
Unit Denominations USD Million/Billion

 

Simultaneously, the escalating prevalence of degenerative disorders has spurred intensive research efforts aimed at developing regenerative therapies. These therapies hold immense promise for addressing chronic conditions with unmet medical needs, presenting lucrative opportunities for companies investing in this burgeoning field. With the potential to target fundamental disease mechanisms, regenerative medicines are at the forefront of medical innovation, offering novel avenues for treatment. Ongoing clinical trials are yielding promising results, positioning the regenerative medicine market for substantial growth in the foreseeable future.

Moreover, the advent of gene-based therapy has revolutionized the treatment landscape, offering targeted solutions for a diverse array of disorders. Gene therapy's precision and efficacy hold tremendous potential for addressing previously untreatable diseases, driving significant growth across multiple medical domains, including oncology, cardiovascular, and neurological disorders. The proliferation of highly efficient products such as grafts, tissue patches, and scaffolds, alongside advancements in nanotechnology, further augments the therapeutic potential of regenerative medicines.

Also, with a robust product pipeline, a favorable regulatory environment, and an increased investment in research & development, the Regenerative Medicine Market is poised for sustained growth, shaping the future of healthcare delivery.


Global Regenerative Medicine Market Research Report: Forecast (2024-2030)

Global Regenerative Medicine Market Driver:

Increasing Investments in R&D Activities Leading to Innovative Product Launches – Increasing market investments have spurred extensive research & development endeavors, with numerous investors backing start-up firms dedicated to pioneering new therapies and products. This trend has facilitated notable mergers, research partnerships, and collaborations aimed at leveraging the mutual benefits of R&D activities. For instance:

  • In 2022, Belgian biotech company Galapagos announced that it would acquire CellPoint and AboundBio to accelerate the development & commercialization of next-generation cell therapies.

Apart from private players, various governments and government-funded research institutes are actively spending on this industry to introduce effective options for the treatment of various chronic diseases, such as cancer, diabetes, cardiovascular diseases, and others.

These strategic partnerships, acquisitions, and government funding initiatives are expected to significantly boost market growth, driving innovation & the development of novel therapies that could potentially transform treatment for various chronic diseases.

Global Regenerative Medicine Market Challenge:

Inadequate Claim Process to Impede Market Growth – The market growth is hindered primarily by the absence of or inadequate claim process for regenerative treatment. Most stem cell therapies are experimental or investigational drugs or treatments due to which there is limited Medicare insurance coverage leading to a considerable proportion of out-of-pocket payments. It only covers expenses of treatments that have been approved by the FDA, such as allogeneic transplantation. For instance:

  • In 2022, as per an article published by DVC Stem, stem cell therapy costs between USD 5,000-USD 50,000 and the cost varies depending on multiple factors, such as the type of stem cell administered, number of cells administered, the quality of cells, source of stem cells, etc.

Hence, the lack of coverage by major insurance providers, forces patients to seek alternative funding methods, like crowdfunding, causing treatment delays, and thus hindering the Regenerative Medicine Market expansion.

Global Regenerative Medicine Market Trend:

Strategic Acquisition by Key Players as a Growing Trend to Boost the Market Growth – One prominent trend in the Global Regenerative Medicine Market involves key players executing strategic acquisitions to enhance their R&D capabilities. The products of this market offer various innovative approaches utilizing living cells, proteins, enzymes, antibodies, Antibody-drug conjugates (ADC), as well as gene & cellular components, leading to life-saving therapies for diverse chronic conditions.

However, there is a potential disparity between expectations and the realities of translating these technologies into clinical practice. Hence, to bridge this gap & advance research across clinical applications, leading regenerative medicine manufacturers are strategically pursuing acquisitions to bolster their R&D capabilities.

Global Regenerative Medicine Market (2024-30): Segmentation Analysis

The Global Regenerative Medicine Market study by MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the regional level. In accordance to the analysis, the market has been further classified as:

Based on the Product:

  • Cell Therapy
    • Stem Cell Therapy
      • Cell Transplantation
      • Stem Cell Therapy Products
    • Cell-based Immunotherapy
  • Gene Therapy
  • Tissue Engineering

The Cell Therapy segment held a significant share of the Global Regenerative Medicine. Cell therapy offers a wide range of benefits, cells such as mesenchymal stem cells play a crucial role in tissue healing & regeneration for injuries and degenerative ailments. Providing personalized treatment tailored to an individual's medical condition and genetic makeup, minimizes side effects and risks of rejection, particularly in autologous cell therapy. Its versatility extends to treating various conditions, including neurological disorders, cardiovascular diseases, autoimmune disorders, and cancers. With the potential for long-lasting results, decreased risk of relapse, and quicker recovery times, cell therapy emerges as a revolutionary element in precision medicine.

By Therapeutic Area:

  • Oncology
  • Musculoskeletal Disorders
  • Dermatology & Wound Care
  • Cardiovascular Diseases
  • Ophthalmology
  • Neurology
  • Others

The Oncology segment emerged as the dominant sector within the Global Regenerative Medicine Market, highlighting its importance within the field. The increasing prevalence of cancer is anticipated to have a positive impact on the global market throughout the forecast period. For instance:

  • In 2023, according to estimates from the American Cancer Society, there were approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths in the US.

This global cancer burden has prompted concerted efforts worldwide to reduce mortality rates and enhance treatment options. Consequently, both government organizations and private companies have made substantial investments in cancer research and the development of advanced regenerative and cell therapies.

Global Regenerative Medicine Market (2019-30): Regional Projection

Geographically, the Global Regenerative Medicine Market expands across:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North America is projected to hold the highest market share due to the presence of key industry players, rapid technological advancements, and significant investments in stem cell & oncology research. The United States, the largest market in the region, is witnessing a rise in diseases like cancer & diabetes, which can now be treated with various stem cell therapies. According to the Heart Disease & Stroke Statistical Fact Sheet 2020, around 40,000 infants in the US are affected by congenital heart defects annually, with about 25% requiring treatment in their first year of life. For instance:

  • In 2022, according to the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030.

Moreover, the Wake Forest Institute for Regenerative Medicine highlights regenerative medicine as the next evolution in medical treatments, with the potential to revolutionize healthcare. This increasing popularity and demand are poised to propel the regional market forward. Furthermore, the increasing burden of chronic diseases presents opportunities for market players, prompting intensified R&D efforts to introduce novel stem cell therapies.

Global Regenerative Medicine Industry Recent Development:

  • 2023: Sarepta and Catalent formed a commercial supply agreement for Catalent to manufacture delandistrigene moxeparvovec (SRP-9001) (ELEVIDYS), Sarpeta’s most advanced gene therapy candidate for the treatment of Duchenne Muscular Dystrophy (DMD).
  • 2023: Bristol Myers Squibb was granted approval for ABECMA for patients with relapsed or refractory myeloma with at least 2 prior treatments, including specific medications in Japan.

Gain a Competitive Edge with Our Global Regenerative Medicine Market Report

  • Global Regenerative Medicine Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  • This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  • Global Regenerative Medicine Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The Regenerative Medicine Market is expected to grow at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2030.

   A. The increasing investments in R&D activities to launch innovative products is driving Regenerative Medicine Market growth during 2024-30.

   A. Novartis AG, Biogen Inc., Amgen Inc., Sarepta Therapeutics Inc.., Medipost Co. Ltd.., Smith+Nephew, JCR Pharmaceuticals Co. Ltd, Takeda Pharmaceuticals, Corestem Inc., Vericell Corporation, Organogenesis Inc., Medtronic, MiMedx Group, Inc., Bristol Myers Squibb Company, Orthocell Ltd., among others are the major companies operating in the Regenerative Medicine Market.

   A. The cell therapy segment based on the type held the largest share of the Regenerative Medicine Market.

   A. North America is expected to dominate the Regenerative Medicine Market during 2024-30.

   A. The strategic acquisition by key players to act as a growing trend shaping the growth of the Regenerative Medicine Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Regenerative Medicine Market Clinical Trial Analysis
  5. Global Regenerative Medicine Market Patent Analysis
  6. Global Regenerative Medicine Market Trends & Insights
  7. Global Regenerative Medicine Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Regenerative Medicine Market Hotspots & Opportunities
  9. Global Regenerative Medicine Market Regulations & Policies
  10. Global Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
        1. Cell Therapy- Market Size & Forecast 2019-2030F, USD Million
          1. Stem Cell Therapy- Market Size & Forecast 2019-2030F, USD Million
            1. Cell Transplantation- Market Size & Forecast 2019-2030F, USD Million
            2. Stem Cell Therapy Products- Market Size & Forecast 2019-2030F, USD Million
              1. Autologous Therapy- Market Size & Forecast 2019-2030F, USD Million
              2. Allogenic Therapy- Market Size & Forecast 2019-2030F, USD Million
          2. Cell-based Immunotherapy- Market Size & Forecast 2019-2030F, USD Million
        2. Gene Therapy- Market Size & Forecast 2019-2030F, USD Million
        3. Tissue Engineering- Market Size & Forecast 2019-2030F, USD Million
      2. By Application
        1. Oncology- Market Size & Forecast 2019-2030F, USD Million
        2. Musculoskeletal Disorders- Market Size & Forecast 2019-2030F, USD Million
        3. Dermatology & Wound Care- Market Size & Forecast 2019-2030F, USD Million
        4. Cardiovascular Diseases- Market Size & Forecast 2019-2030F, USD Million
        5. Ophthalmology- Market Size & Forecast 2019-2030F, USD Million
        6. Neurology- Market Size & Forecast 2019-2030F, USD Million
        7. Others- Market Size & Forecast 2019-2030F, USD Million
      3. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      4. By Company
        1. Market Share of Top Companies
        2. Competition Characteristics
  11. North America Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Million
      2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    4. Canada Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    5. Mexico Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
  12.  South America Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Million
      2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
  13. Europe Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Million
      2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    4. The UK Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    5. France Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    6. Italy Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    7. Spain Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
  14. The Middle East & Africa Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Million
      2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    4. South Africa Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
  15. Asia-Pacific Regenerative Medicine Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Million
      2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
      3. By Country
        1. China
        2. Japan
        3. India
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    4. Japan Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    5. India Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    6. South Korea Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
    7. Australia Regenerative Medicine Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Million
        2. By Therapeutic Area- Market Size & Forecast 2019-2030F, USD Million
  16. Global Regenerative Medicine Market Key Strategic Imperatives for Growth & Success
  17. Competition Outlook
    1. Company Profiles
      1. Novartis AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Biogen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Amgen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Sarepta Therapeutics Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Medipost Co. Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Smith+Nephew
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. JCR Pharmaceuticals Co. Ltd
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Takeda Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Corestem Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Vericell Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Organogenesis Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Medtronic
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. MiMedx Group, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Bristol Myers Squibb Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Orthocell Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


Regenerative Medicine Market Segmentation